Armistice Capital »

Axogen shares owned by Armistice Capital

Quarter-by-quarter ownership of Axogen (AXGN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Axogen

Tip: Access up to 7 years of quarterly data

All positions including Axogen held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axogen by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $21M 1.2M 17.84
2024-12-31 $10M 613k 16.48
2024-09-30 $5.6M 400k 14.02

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Axogen

First Light Asset Management
BlackRock
Vanguard Group
Morgan Stanley
Arrowpoint Asset Management
Soleus Capital Management
Daniel D. Thurber
Balyasny Asset Management
Assenagon Asset Management
Armistice Capital
State Street Corporation
Geode Capital Management
Bessemer
Dimensional Fund Advisors
DAFNA Capital Management

View all funds holding Axogen